Brief: Calidi Biotherapeutics Prices $4.25 Million Public Offering Of Common Stock
10/01/2025 13:59
Jan 10 (Reuters) - Calidi Biotherapeutics Inc CLDI.A :
* CALIDI BIOTHERAPEUTICS ANNOUNCES PRICING OF $4.25 MILLION
PUBLIC
OFFERING OF COMMON STOCK
* CALIDI BIOTHERAPEUTICS INC - PRICES PUBLIC OFFERING AT
$0.85 PER
SHARE
Source text: urn:newsml:reuters.com:*:nGNX4Pdgbn
Further company coverage: CLDI.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma